
Advanced Enzyme Technologies Ltd Upgraded to Hold on Technical Improvements and Market Performance
2026-04-28 08:42:49Advanced Enzyme Technologies Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in technical indicators and market returns despite flat financial results. The upgrade, effective from 27 April 2026, is driven primarily by a shift in technical trends, valuation considerations, and a stable financial position, positioning the small-cap pharmaceutical company for cautious optimism among investors.
Read full news article
Advanced Enzyme Technologies Ltd Shows Renewed Momentum Amid Mixed Technical Signals
2026-04-28 08:05:15Advanced Enzyme Technologies Ltd has witnessed a notable shift in its technical momentum, moving from a mildly bearish stance to a mildly bullish outlook. This change is underscored by a robust 10.56% gain in the stock price on 28 Apr 2026, signalling renewed investor interest amid mixed technical indicator signals and a favourable comparison against benchmark indices.
Read full news article
Advanced Enzyme Technologies Ltd Surges 7.09% to Day's High of Rs 320.65 — Outperforms Sector by 5.64 Percentage Points
2026-04-27 11:45:57The Sensex advanced 0.39% on 27 Apr 2026, yet Advanced Enzyme Technologies Ltd outpaced the broader market with a 7.09% gain, reaching an intraday high of Rs 320.65. This 5.64 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a market-wide lift.
Read full news article
Advanced Enzyme Technologies Ltd is Rated Sell
2026-04-26 10:10:02Advanced Enzyme Technologies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 21 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 26 April 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Advanced Enzyme Technologies Ltd is Rated Sell
2026-04-15 10:10:03Advanced Enzyme Technologies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 21 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 15 April 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Advanced Enzyme Technologies Ltd Sees Mixed Technical Signals Amid Mild Momentum Shift
2026-04-09 08:05:40Advanced Enzyme Technologies Ltd has experienced a notable shift in price momentum, reflected in a complex blend of technical indicator signals. Despite a recent 4.64% rise in the stock price to ₹294.20, the overall technical landscape remains cautiously bearish, with key metrics such as MACD and moving averages signalling mild weakness. This nuanced technical picture warrants close attention from investors navigating the Pharmaceuticals & Biotechnology sector.
Read full news article
Advanced Enzyme Technologies Ltd is Rated Sell
2026-04-04 10:10:02Advanced Enzyme Technologies Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 21 Nov 2025, reflecting a shift in the stock’s outlook. However, the analysis and financial metrics discussed here are based on the company’s current position as of 04 April 2026, providing investors with the latest insights into its performance and valuation.
Read full news article
Markets Rally, But Advanced Enzyme Technologies Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off
2026-03-30 14:01:32While broader indices showed signs of recovery, Advanced Enzyme Technologies Ltd slipped to a fresh 52-week low of Rs 252.75 on 30 Mar 2026, extending its recent downward momentum amid sector headwinds and company-specific concerns.
Read full news article
Advanced Enzyme Technologies Ltd is Rated Sell
2026-03-24 10:10:02Advanced Enzyme Technologies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 21 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 24 March 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.
Read full news articleAdvanced Enzyme Technologies Limited - Other General Purpose
28-Nov-2019 | Source : NSEAdvanced Enzyme Technologies Limited has informed the Exchange regarding Disclosure of Related Party Transaction disclosure under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Advanced Enzyme Technologies Limited - Clarification
18-Nov-2019 | Source : NSEAdvanced Enzyme Technologies Limitedmited with respect to announcement dated 02-Nov-2019, regarding Board meeting held on November 02, 2019. On basis of above you are required to clarify following - 1. Date of such binding agreement, if any, entered for sale of such unit/division, if any; 2. Amount & percentage of turnover or revenue or income and net worth of the listed entity contributed by such unit or division during the last financial year; 3. Date of closure or estimated time of closure. The response of the Company is awaited.
Advanced Enzyme Technologies Limited - Analysts/Institutional Investor Meet/Con. Call Updates
05-Nov-2019 | Source : NSEAdvanced Enzyme Technologies Limitedited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates with Fidelity International, Singapore on 5th November 2019.
Corporate Actions
No Upcoming Board Meetings
Advanced Enzyme Technologies Ltd has declared 60% dividend, ex-date: 23 Jul 25
Advanced Enzyme Technologies Ltd has announced 2:10 stock split, ex-date: 25 May 17
No Bonus history available
No Rights history available






